Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Risk of Multiple Sclerosis in Patients with Psoriasis : A Danish Nationwide Cohort Study. / Egeberg, Alexander; Mallbris, Lotus; Gislason, Gunnar Hilmar; Skov, Lone; Hansen, Peter Riis.

I: Journal of Investigative Dermatology, Bind 136, Nr. 1, 01.2016, s. 93-98.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Egeberg, A, Mallbris, L, Gislason, GH, Skov, L & Hansen, PR 2016, 'Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study', Journal of Investigative Dermatology, bind 136, nr. 1, s. 93-98. https://doi.org/10.1038/jid.2015.350

APA

Egeberg, A., Mallbris, L., Gislason, G. H., Skov, L., & Hansen, P. R. (2016). Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study. Journal of Investigative Dermatology, 136(1), 93-98. https://doi.org/10.1038/jid.2015.350

Vancouver

Egeberg A, Mallbris L, Gislason GH, Skov L, Hansen PR. Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study. Journal of Investigative Dermatology. 2016 jan.;136(1):93-98. https://doi.org/10.1038/jid.2015.350

Author

Egeberg, Alexander ; Mallbris, Lotus ; Gislason, Gunnar Hilmar ; Skov, Lone ; Hansen, Peter Riis. / Risk of Multiple Sclerosis in Patients with Psoriasis : A Danish Nationwide Cohort Study. I: Journal of Investigative Dermatology. 2016 ; Bind 136, Nr. 1. s. 93-98.

Bibtex

@article{f43d9cdbd7be4a7c868c7f880838a665,
title = "Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study",
abstract = "Psoriasis and multiple sclerosis (MS) are inflammatory disorders with similarities in genetic risk variants and inflammatory pathways. Limited evidence is available on the relationship between the two diseases. We therefore investigated the risk of incident (new-onset) MS in patients with mild and severe psoriasis, respectively. All Danish citizens aged ≥18 years from January 1, 1997 to December 31, 2011 were identified by linkage of nationwide registries at the individual level. We estimated incidence rate ratios (IRRs) adjusted for age, gender, socio-economic status, smoking, medication, comorbidity, and ultraviolet phototherapy, by Poisson regression. There were 58,628 and 9,952 cases of mild and severe psoriasis, and 9,713 cases of MS, respectively. Incidence rates (IRs) of MS per 10,000 person years for the reference population, mild psoriasis, and severe psoriasis were 1.78, 3.22, and 4.55, respectively. Adjusted IRRs of MS were 1.84 (95% confidence interval [CI] 1.46 to 2.30), and 2.61 (95% CI 1.44 to 4.74) in mild and severe psoriasis, respectively. Similar results were observed when adjustment for family history of MS was included in the analyses. Psoriasis may confer a disease severity-dependent risk of MS. Further studies are warranted to establish the mechanisms underlying this relationship and its potential clinical consequences.Journal of Investigative Dermatology accepted article preview online, 09 September 2015. doi:10.1038/jid.2015.350.",
author = "Alexander Egeberg and Lotus Mallbris and Gislason, {Gunnar Hilmar} and Lone Skov and Hansen, {Peter Riis}",
year = "2016",
month = jan,
doi = "10.1038/jid.2015.350",
language = "English",
volume = "136",
pages = "93--98",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "nature publishing group",
number = "1",

}

RIS

TY - JOUR

T1 - Risk of Multiple Sclerosis in Patients with Psoriasis

T2 - A Danish Nationwide Cohort Study

AU - Egeberg, Alexander

AU - Mallbris, Lotus

AU - Gislason, Gunnar Hilmar

AU - Skov, Lone

AU - Hansen, Peter Riis

PY - 2016/1

Y1 - 2016/1

N2 - Psoriasis and multiple sclerosis (MS) are inflammatory disorders with similarities in genetic risk variants and inflammatory pathways. Limited evidence is available on the relationship between the two diseases. We therefore investigated the risk of incident (new-onset) MS in patients with mild and severe psoriasis, respectively. All Danish citizens aged ≥18 years from January 1, 1997 to December 31, 2011 were identified by linkage of nationwide registries at the individual level. We estimated incidence rate ratios (IRRs) adjusted for age, gender, socio-economic status, smoking, medication, comorbidity, and ultraviolet phototherapy, by Poisson regression. There were 58,628 and 9,952 cases of mild and severe psoriasis, and 9,713 cases of MS, respectively. Incidence rates (IRs) of MS per 10,000 person years for the reference population, mild psoriasis, and severe psoriasis were 1.78, 3.22, and 4.55, respectively. Adjusted IRRs of MS were 1.84 (95% confidence interval [CI] 1.46 to 2.30), and 2.61 (95% CI 1.44 to 4.74) in mild and severe psoriasis, respectively. Similar results were observed when adjustment for family history of MS was included in the analyses. Psoriasis may confer a disease severity-dependent risk of MS. Further studies are warranted to establish the mechanisms underlying this relationship and its potential clinical consequences.Journal of Investigative Dermatology accepted article preview online, 09 September 2015. doi:10.1038/jid.2015.350.

AB - Psoriasis and multiple sclerosis (MS) are inflammatory disorders with similarities in genetic risk variants and inflammatory pathways. Limited evidence is available on the relationship between the two diseases. We therefore investigated the risk of incident (new-onset) MS in patients with mild and severe psoriasis, respectively. All Danish citizens aged ≥18 years from January 1, 1997 to December 31, 2011 were identified by linkage of nationwide registries at the individual level. We estimated incidence rate ratios (IRRs) adjusted for age, gender, socio-economic status, smoking, medication, comorbidity, and ultraviolet phototherapy, by Poisson regression. There were 58,628 and 9,952 cases of mild and severe psoriasis, and 9,713 cases of MS, respectively. Incidence rates (IRs) of MS per 10,000 person years for the reference population, mild psoriasis, and severe psoriasis were 1.78, 3.22, and 4.55, respectively. Adjusted IRRs of MS were 1.84 (95% confidence interval [CI] 1.46 to 2.30), and 2.61 (95% CI 1.44 to 4.74) in mild and severe psoriasis, respectively. Similar results were observed when adjustment for family history of MS was included in the analyses. Psoriasis may confer a disease severity-dependent risk of MS. Further studies are warranted to establish the mechanisms underlying this relationship and its potential clinical consequences.Journal of Investigative Dermatology accepted article preview online, 09 September 2015. doi:10.1038/jid.2015.350.

U2 - 10.1038/jid.2015.350

DO - 10.1038/jid.2015.350

M3 - Journal article

C2 - 26352056

VL - 136

SP - 93

EP - 98

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 1

ER -

ID: 164437846